Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: DNA methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load

PROVIDER: PRJNA488496 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7768120_1.fastq.gz	Fastqsanger.gz
	SRR7768120_2.fastq.gz	Fastqsanger.gz
	SRR7768130_1.fastq.gz	Fastqsanger.gz
	SRR7768130_2.fastq.gz	Fastqsanger.gz
	SRR7768140_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 160

Similar Datasets

DNA methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load

Project description:DNA methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load

| PRJNA488256 | ENA

DNA methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load [RNA-seq]

Project description:DNA methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load [RNA-seq]

| PRJNA557841 | ENA

DNA methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load [RNA-seq]

Project description:Mitotic cell division increases tumour mutation burden and copy number load, predictive markers of the clinical benefit of immunotherapy. Cell division correlates also with genomic demethylation involving methylation loss in late-replicating partial methylation domains. Here we find that immunomodulatory pathway genes are concentrated in these domains and transcriptionally repressed in demethylated tumours with CpG island promoter hypermethylation. Global methylation loss correlated with immune evasion signatures independently of mutation burden and aneuploidy. Methylome data of our cohort (n = 60) and a published cohort (n = 81) in lung cancer and a melanoma cohort (n = 40) consistently demonstrated that genomic methylation alterations counteract the contribution of high mutation burden and increase immunotherapeutic resistance. Higher predictive power was observed for methylation loss than mutation burden. We also found that genomic hypomethylation correlates with the immune escape signatures of aneuploid tumours. Hence, DNA methylation alterations implicate epigenetic modulation in precision immunotherapy.

2019-08-02 | GSE135222 | GEO

DNA methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load

Project description:Mitotic cell division increases tumour mutation burden and copy number load with a positive and inverse correlation, respectively, with the clinical benefit of immunotherapy. Markers of cell division correlate also with genomic demethylation involving methylation loss in late-replicating partial methylation domains. Here we find that immunomodulatory pathway genes are concentrated in these domains and transcriptionally repressed in demethylated tumours with CpG island promoter hypermethylation. Global methylation loss correlated with immune evasion signatures independently of mutation burden and aneuploidy. Methylome data of our cohort (n = 60) and a published cohort (n = 81) in lung cancer and a melanoma cohort (n = 40) consistently demonstrated that genomic methylation alterations counteract the contribution of high mutation burden and increase immunotherapeutic resistance. Higher predictive power was observed for methylation loss than mutation burden. We also found that genomic hypomethylation correlates with the immune escape signatures of aneuploid tumours. Hence, DNA methylation alterations implicate epigenetic modulation as a combination regimens for precision immunotherapy.

2019-07-31 | GSE119144 | GEO

DNA Methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load

| EGAS00001003731 | EGA

GNPS - Metabolomics data for Figure 1D-1F. Schofield et al, Cell Reports,

Project description:Metabolomics raw LCMS files for Figure 1D-1F. Schofield et al, Cell Reports, "Acod1 Expression in Cancer Cells Promotes Immune Evasion through the Generation of Inhibitory Peptides".

2024-03-03 | MSV000094226 | GNPS

Chronic viral mimicry induction following p53 loss promotes immune evasion

Project description:Chronic viral mimicry induction following p53 loss promotes immune evasion

| PRJNA896220 | ENA

KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance.

Project description:KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance.

| PRJNA1008251 | ENA

Chronic viral mimicry induction following p53 loss promotes immune evasion [Mouse RNASeq]

Project description:Chronic viral mimicry induction following p53 loss promotes immune evasion [Mouse RNASeq]

| PRJNA896208 | ENA

KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance [scRNA-seq]

Project description:KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance [scRNA-seq]